HomeBusinessHopkinton Drug sold to Texas company

Hopkinton Drug sold to Texas company

Published on

Foemmel Fine Homes

In a letter, Hopkinton Drug’s founder Dennis Katz announced his simultaneous retirement and the sale of Hopkinton Drug, Compounding & Wellness to PD Labs of Cedar Park, Texas. Katz thanked his many friends and customers for providing him “a long and rewarding journey” in Hopkinton.

Prescriptions will automatically be transferred to PD Labs, who will begin filling them on December 6th, 2022.

Metrowest YMCA Summer Camp

Latest articles

Catch up with a briefing of the most important and interesting stories from Hopkinton delivered to your inbox.

More like this